[NMusers] Testing nmusers system. 1001. Please ignore

Testing nmusers system. 1001. Please ignore. Robert J. Bauer, Ph.D. Senior Director Pharmacometrics R ICON Early Phase 731 Arbor way, suite 100 Blue Bell, PA 19422 Office: (215) 616-6428 Mobile: (925) 286-0769 robert.ba...@iconplc.com<mailto:robert.ba...@iconplc.com> www.iconplc.co

[NMusers] Testing nmusers. Pleas ignore. No. 1002

Testing nmusers. Please ignore. ICON plc made the following annotations. -- This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named

[NMusers] testing nmusers system, please ignore, 1367

Testing nmusers system, please ignore, 1367 ICON plc made the following annotations. -- This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual

[NMusers] To: "nmusers@globomaxnm.com"

Unsubscribe

[NMusers] Re: [NMusers] Unsubscribe

Please unsubscribe me from the mailing list.thanks. On Wed, 02 Jun 2021 20:48:31 +0530 Eileen Castronova wrote > iWe couldn't verify the > sender of this email.Please unsubscribe me from the mailing list.thanks, Eileen On

[NMusers] To: nmusers@globomaxnm.com

Please unsubscribe me from your mailing list

[NMusers] testing nmusers #8910, please ignore.

Testing nmusers. Please ignore. ICON plc made the following annotations. -- This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named

[NMusers] testing nmusers number 101. Please ignore

testing number 101

[NMusers] To: nmusers

Dear All, I'm working on the population pharmacokinetics of a mAb, in this study 4 dose levels (50, 100, 200 and 400 mg) were evaluated. I tested different models, but none of them fit well; that's why I decided to find for each dose level the best model. I found the two lower dose levels fitted

[NMusers] testing nmusers number 12000. Please ignore

Testing nmusers ICON plc made the following annotations. -- This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail

[NMusers] Testing nmusers, number 500. PLease ignore

Testing number 500 ICON plc made the following annotations. -- This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail

[NMusers] testing nmusers (500). Please ignore.

Test 500.0 Robert J. Bauer, Ph.D. Pharmacometrics R ICON Early Phase 820 W. Diamond Avenue Suite 100 Gaithersburg, MD 20878 Office: (215) 616-6428 Mobile: (925) 286-0769 robert.ba...@iconplc.com www.iconplc.com ICON plc made the following

[NMusers] testing nmusers. please ignore (400).

Testing 400 Robert J. Bauer, Ph.D. Pharmacometrics R ICON Early Phase 820 W. Diamond Avenue Suite 100 Gaithersburg, MD 20878 Office: (215) 616-6428 Mobile: (925) 286-0769 robert.ba...@iconplc.com www.iconplc.com ICON plc made the

[NMusers] Testing nmusers. Please ignore (304)

Test 304 Robert J. Bauer, Ph.D. Pharmacometrics R ICON Early Phase 820 W. Diamond Avenue Suite 100 Gaithersburg, MD 20878 Office: (215) 616-6428 Mobile: (925) 286-0769 robert.ba...@iconplc.com www.iconplc.com ICON plc made the following

[NMusers] testing nmusers, please ignore

testing Robert J. Bauer, Ph.D. Pharmacometrics R ICON Early Phase 820 W. Diamond Avenue Suite 100 Gaithersburg, MD 20878 Office: (215) 616-6428 Mobile: (925) 286-0769 robert.ba...@iconplc.com www.iconplc.com ICON plc made the following

[NMusers] testing nmusers, pleaase ignore.

Robert J. Bauer, Ph.D. Pharmacometrics R ICON Early Phase 820 W. Diamond Avenue Suite 100 Gaithersburg, MD 20878 Office: (215) 616-6428 Mobile: (925) 286-0769 robert.ba...@iconplc.com www.iconplc.com ICON plc made the following

[NMusers] testing nmusers 270

Testing 270 Robert J. Bauer, Ph.D. Pharmacometrics R ICON Early Phase 820 W. Diamond Avenue Suite 100 Gaithersburg, MD 20878 Office: (215) 616-6428 Mobile: (925) 286-0769 robert.ba...@iconplc.com www.iconplc.com ICON plc made the following annotations.

[NMusers] testing nmusers number 219

testing 219

[NMusers] testing nmusers 276

Testing 276 Robert J. Bauer, Ph.D. Pharmacometrics R ICON Early Phase 820 W. Diamond Avenue Suite 100 Gaithersburg, MD 20878 Office: (215) 616-6428 Mobile: (925) 286-0769 robert.ba...@iconplc.com www.iconplc.com ICON plc made the

[NMusers] Re: [NMusers] 答复: [NMusers] A question about handling large-scale data

[mailto:owner-nmus...@globomaxnm.com] *代表 *Nick Holford *发送时间:* 2014年11月20日 15:40 *收件人:* Liudongyang_hotmail; nmusers@globomaxnm.com *主题:* Re: [NMusers] A question about handling large-scale data Dear Dongyang, Transforming H+ concentration to the pH scale seems a reasonable idea. However I would

[NMusers] testing nmusers, please ignore

Testing nmusers, please ignore. Robert J. Bauer, Ph.D. Vice President, Pharmacometrics, RD ICON Development Solutions 7740 Milestone Parkway Suite 150 Hanover, MD 21076 Tel: (215) 616-6428 Mob: (925) 286-0769 Email: robert.ba...@iconplc.commailto:robert.ba...@iconplc.com Web: www.iconplc.comhttp

[NMusers] Re: [NMusers] $Error with log-transf​ormation

what is your rationale to use rat data for population analysis with 6 etas? On Mon, Apr 30, 2012 at 8:41 AM, siwei Dai ellen.siwei...@gmail.com wrote: Hi, NM users: I am a new NONMEM user and wish to get help from NM experts. I have a data from rats with concentration measured in both

[NMusers] Re: [NMusers] $Error with log-transf​ormation

Dr. Singh: Thank you for asking. We see great BSV in the data, although some of the etas probably will need to be fixed to zero. Also, we may want to use the same structure model for a human study. Thank you! Siwei On Mon, Apr 30, 2012 at 10:29 AM, indrajeet singh isingh...@gmail.comwrote:

[NMusers] FW: nmusers matters

To: Bachman, William Subject: nmusers matters Bill: I received one nmusers item from a Hauke Rus. Did you get it as well? I think it would be good if you announced on nmusers our difficulties, and that the messages since Nov 14 were lost, so they should re-issue their message if they wish

[NMusers] RE: [NMusers] Re: 答复: [NMusers] NONMEM execution problem

...@globomaxnm.com] On Behalf Of Gaurav Bajaj Sent: Wednesday, September 14, 2011 3:49 PM To: nmusers@globomaxnm.com Subject: [NMusers] Re: 答复: [NMusers] NONMEM execution problem Dear NONMEM users, I recently shared a NONMEM 7.2 execution problem with the group which was due to compiler issues. I

[NMusers] Re: [NMusers] Re: 答复: [NMusers] NONMEM execution problem

compiler set F77HOME=C:\Program Files\gfortran set F77VER=gf good luck! Kun Wang From: Gaurav Bajaj Sent: Thursday, September 15, 2011 3:48 AM To: nmusers@globomaxnm.com Subject: [NMusers] Re: 答复: [NMusers] NONMEM execution problem Dear NONMEM users, I recently shared a NONMEM 7.2 execution

Fwd: Re: [NMusers] RE: [NMusers] Zähneputzen VOR oder NACH dem Frühstück? What comes first? BSV, BOV, or covariates?

Cc: 'nmusers' Subject: Re: [NMusers] Zähneputzen VOR oder NACH dem Frühstück? What comes first? BSV, BOV, or covariates? Thank you Elodie, the reference you mention also states that the covariates were tested only on parameters for which BOV and BSV were significant. This is generally

Re: [NMusers] RE: [NMusers] Zähneputzen VOR oder NACH dem Frühstück? What comes fir st? BSV, BOV, or covariates?

-Original Message- From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On Behalf Of Paolo Denti Sent: Wednesday, 17 November, 2010 17:23 To: Elodie Plan Cc: 'nmusers' Subject: Re: [NMusers] Zähneputzen VOR oder NACH dem Frühstück? What comes first? BSV, BOV

Re: [NMusers] RE: [NMusers] Zähneputzen VOR oder NACH dem Frühstück? What comes fir st? BSV, BOV, or covariates?

-Original Message- From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On Behalf Of Paolo Denti Sent: Wednesday, 17 November, 2010 17:23 To: Elodie Plan Cc: 'nmusers' Subject: Re: [NMusers] Zähneputzen VOR oder NACH dem Frühstück? What comes first? BSV, BOV, or covariates

[NMusers] RE: [NMusers] Zähneputzen VOR oder NACH dem Früh stück? What comes first? BSV, BOV, or covariat es?

[mailto:owner-nmus...@globomaxnm.com] On Behalf Of Paolo Denti Sent: Wednesday, 17 November, 2010 17:23 To: Elodie Plan Cc: 'nmusers' Subject: Re: [NMusers] Zähneputzen VOR oder NACH dem Frühstück? What comes first? BSV, BOV, or covariates? Thank you Elodie, the reference you mention also states

[NMusers] Re: [NMusers] RE: [NMusers] Zähn eputzen VOR oder NACH dem Frühst ück? What comes first? BSV, BOV, or covariates?

To: Elodie Plan Cc: 'nmusers' Subject: Re: [NMusers] Zähneputzen VOR oder NACH dem Frühstück? What comes first? BSV, BOV, or covariates? Thank you Elodie, the reference you mention also states that the covariates were tested only on parameters for which BOV and BSV were significant

[NMusers] RE: [NMusers] Zähneputzen VOR oder NACH dem Früh stück? What comes first? BSV, BOV, or covariat es?

Dear Paolo, Thanks for this interesting NMusers thread. I think the order you are describing really makes sense in theory, for the reasons you describe, but in brief because it seems covariates should be incorporated on a model already fully developed structurally and statistically, so

[NMusers] RE: [NMusers] model dynamic data with $DES subroutine

03, 2009 9:29 AM To: nmusers@globomaxnm.com Subject: [NMusers] model dynamic data with $DES subroutine Dear NMusers, I have a question I would like your help. The data I have is only the dynamic data since we didn't give dose to the animal. I am trying to capture the nature of disease progression

RE: [NMusers] RE: [NMusers] NM6.1 on Apple-OSX using g95 compiler

the compiler and linker to understand what is going on here - how much storage is actually being set aside for these commons and what impact if any does that have on the data to be stored there?? My hope would be that some of the nmusers who are more knowledgeable than I am might be able to cast some

[NMusers] RE: [NMusers] RE: [NMusers] NM6.1 on Apple-OSX using g95 compiler

showed no difference in results (in a limited sample of runs). Bill _ From: Dunne, Adrian [PRDBE Extern] [mailto:adun...@its.jnj.com] Sent: Wednesday, December 02, 2009 12:50 PM To: Bill Bachman Cc: nmusers@globomaxnm.com; Nandy, Partha [PRDUS] Subject: RE: [NMusers] RE: [NMusers] NM6.1

[NMusers] RE: [NMusers] add an item to the table after completion of a run

If you used the MSFO option on the $EST record, you can do an $MSFI run with MAX=0 to repeat the table creation. _ From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On Behalf Of Ethan Wu Sent: Tuesday, March 10, 2009 8:16 AM To: nmusers@globomaxnm.com Subject

[NMusers] RE: [NMusers] add an item to the table after completion of a run

that was the case. _ From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On Behalf Of Ethan Wu Sent: Tuesday, March 10, 2009 8:54 AM To: Bill Bachman; nmusers@globomaxnm.com Subject: Re: [NMusers] add an item to the table after completion of a run Hi Bill, yes

[NMusers] RE: [NMusers] Installation of PsN

. _ From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of Mulla Hussain - Senior Pharmacist Sent: Wednesday, December 03, 2008 6:30 AM To: nmusers@globomaxnm.com Subject: [NMusers] Installation of PsN Dear all, Could somebody please offer some advice? I am trying

[NMusers] RE: [NMusers] Coding RATE or II at SS

Rate is zero for an extravascular dose (like an oral dose), rate is 0 for infusions. _ From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of Khaled Nm Sent: Tuesday, April 15, 2008 10:36 AM To: nmusers@globomaxnm.com Subject: [NMusers] Coding RATE or II at SS Dear nmusers

[NMusers] RE: [NMusers] NM VI and NMV gave different results

_ From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of Jian Xu Sent: Wednesday, April 09, 2008 11:28 AM To: nmusers@globomaxnm.com Subject: [NMusers] NM VI and NMV gave different results Dear all, I did a Pop PK a year ago in NM V, and got a stable model and reasonable

Re: [NMusers] Re: [NMUSERS] Questions on fitting pediatric PK data using NONMEM

Winnie, If you are serious about modelling PK in children then I suggest you become familiar with some basic concepts of scaling for size and maturational changes with age (see Anderson Holford 2008). These can be readily implemented in NONMEM. In preparing your data the important thing is

[NMusers] Re: [NMUSERS] Questions on fitting pediatric PK data using NONMEM

Hello all I work with small number of pediatric inpatients with few samples from each patient of various age and weights. I am a novice in using NONMEM. I would appreciate advice on fitting the data using various dose inputs - should we normalize the dose and other parameters by weights ?